Related Experiment Video
Updated: Jun 7, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
A novel SERPINC1 c.119G>A (p.Cys40Tyr) mutation with variable clinical expression in an Indian family
Kranti Patil1, Asha Shah2, Gurpreet Saini1
1Advanced Center for Oncology, Hematology and Rare Disorders (ACOHRD), K.J. Somaiya Super Speciality Hospital & Research Center, Somaiya Ayurvihar, Sion East.
Insights
A novel SERPINC1 mutation causes severe hereditary antithrombin deficiency, leading to early-onset pulmonary thromboembolism in two brothers. Their father, with the same mutation, remained asymptomatic, suggesting other genetic factors may influence disease severity.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Hereditary antithrombin (AT) deficiency, caused by SERPINC1 mutations, is a severe form of thrombophilia.
- Understanding genetic variants is crucial for predicting thrombotic risk.
Purpose of the Study:
- To report a novel SERPINC1 mutation (c.119 G>A, p.Cys40Tyr) in a family with hereditary AT deficiency.
- To investigate the genetic basis of varying thrombotic phenotypes within the family.
Main Methods:
- Clinical exome sequencing was performed on three family members.
- In-silico prediction tools (PolyPhen-2, SIFT, MutationTaster) assessed the novel variant's pathogenicity.
- Analysis included SERPINC1 and common thrombophilia-associated genes like SERPINE1.
Main Results:
- A novel SERPINC1 mutation (c.119 G>A, p.Cys40Tyr) was identified in all three affected family members.
- Two brothers presented with acute pulmonary thromboembolism (PTE) at ages 18 and 21.
- The asymptomatic father (58 years) carried the same SERPINC1 mutation, but was heterozygous for the SERPINE1 -844 G>A variant, unlike his homozygous sons.
Conclusions:
- The novel SERPINC1 mutation is associated with hereditary AT deficiency and a high risk of early-onset PTE.
- The differing clinical presentations suggest that other genetic factors, such as the SERPINE1 variant, may modulate thrombotic risk and disease severity.
Abstract:
Hereditary antithrombin (AT) deficiency due to mutations in SERPINC1 is known to be the most severe form of thrombophilia. We report three members in a family with hereditary AT deficiency with a novel mutation in exon 2 of SERPINC1, that is c.119 G>A (p.Cys40Tyr). Two brothers presented with acute pulmonary thromboembolism (PTE) at 18 and 21 years of age, whereas their 58-year-old father did not have any thrombotic episode till date. The in-silico prediction of the variant was found to be highly damaging by PolyPhen-2, SIFT and MutationTaster. Clinical exome sequencing did not show any strong coinherited thrombophilia genes, except SERPINE1 -844 G>A variant in homozygous state in the two affected brothers as compared to the father who was heterozygous for this variant. The additive effect of SERPINE1 variant in the clinical expression in two siblings cannot be ruled out, in the absence of any other known environmental triggering factors.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Incomplete Dominance
Pleiotropy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...

